Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC (GAIN)
Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC (ICC/ECC) - A Phase III Study of the German Registry of Incidental Gallbladder Carcinoma Platform (GR) - The AIO/ CALGP/ ACO- GAIN-Trial -
Sponsor: German Research Foundation
A PHASE3 clinical study on Biliary Tract Cancer and Incidental Gallbladder Carcinoma, this trial is completed. The trial is conducted by German Research Foundation and has accumulated 11 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Dec 2024 — Present [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Sep 2024 — Dec 2024 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Apr 2024 — Jul 2024 [monthly]
Recruiting PHASE3
-
Sep 2022 — Apr 2024 [monthly]
Recruiting PHASE3
▶ Show 6 earlier versions
-
Jan 2021 — Sep 2022 [monthly]
Recruiting PHASE3
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Dec 2019 — Oct 2020 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Mar 2019 — Dec 2019 [monthly]
Not Yet Recruiting PHASE3
-
Feb 2019 — Mar 2019 [monthly]
Not Yet Recruiting PHASE3
-
Oct 2018 — Feb 2019 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- German Research Foundation
- Krankenhaus Nordwest
For direct contact, visit the study record on ClinicalTrials.gov .